Basic fibroblast growth factor increases intracellular magnesium concentration through the specific signaling pathways

Molecules and Cells

Volumn 28, Issue 1, 2009, Pages 13-17

  Hong, Bing Zhe ^a,c   Park, Sun Ah ^a   Kim, Han Na ^a   Ma, Tian Ze ^a   Kim, Han Gyu ^a   Kang, Hyung Sub ^b   Kim, Hwan Gyu ^b   Kwak, Yong Geun ^a  

^a Chonbuk National University Medical School   (South Korea)

^b Chonbuk National University   (South Korea)

^c DALIAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Human umbilical vein endothelial cells; Magnesium; Signal transduction

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 2 MORPHOLINO 8 PHENYLCHROMONE; 4 (4 FLUOROPHENYL) 2 (4 HYDROXYPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; BASIC FIBROBLAST GROWTH FACTOR; GENISTEIN; MAGNESIUM ION; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE B; TYROSINE KINASE RECEPTOR; TYRPHOSTIN; TYRPHOSTIN A 23; UNCLASSIFIED DRUG; WORTMANNIN;

ARTICLE; CELL LEVEL; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANDROSTADIENES; CELL LINE; CHROMONES; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIAL CELLS; ESTRENES; FIBROBLAST GROWTH FACTOR 2; FLAVONOIDS; GENISTEIN; HUMANS; IMIDAZOLES; INTRACELLULAR SPACE; MAGNESIUM; MICROSCOPY, FLUORESCENCE; MORPHOLINES; PHOSPHOLIPASE C GAMMA; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRIDINES; PYRROLIDINONES; SIGNAL TRANSDUCTION; TYRPHOSTINS;

EID: 69849083758     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10059-009-0103-2     Document Type: Article

References (37)

1. Bussolino, F., Mantovani, A., and Persico, G. (1997). Molecular mechanisms of blood vessel formation. Trends Biochem. Sci. 22, 251-256.
2. Cines, D.B., Pollak, E.S., Buck, C.A., Loscalzo, J., Zimmerman, G.A., McEver, R.P., Pober, J.S., Wick, T.M., Konkle, B.A., Schwartz, B.S., et al. (1998). Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 91, 3527-3561.
3. Folkman, J., and Shing, Y. (1992). Angiogenesis. J. Biol. Chem. 267, 10931-10934.
4. Giavazzi, R., Giuliani, R., Coltrini, D., Bani, M.R., Ferri, C., Sennino, B., Tosatti, M.P., Stoppacciaro, A., and Presta, M. (2001). Modulation of tumor angiogenesis by conditional expression of fibroblast growth factor-2 affects early but not established tumors. Cancer Res. 61, 309-317.
5. Gunther, T. (1986). Functional compartmentation of intracellular magnesium. Magnesium 5, 53-59.
6. Hackett, S.F., Friedman, Z., and Campochiaro, P.A. (1987). Cyclic 3′,5′-adenosine monophosphate modulates vascular endothelial cell migration in vitro. Cell Biol. Int. Rep. 11, 279-287.
7. Hong, B.Z., Kang, H.S., So, J.N., Kim, H.N., Park, S.A., Kim, S.J., Kim, K.R., and Kwak, Y.G. (2006). Vascular endothelial growth factor increases the intracellular magnesium. Biochem. Biophys. Res. Commun. 347, 496-501.
8. 2+ by bombesin in Swiss 3T3 cells: mobilization through external Ca(2+) - and tyrosine kinase-dependent mechanisms. J. Biochem. 115, 730-737.
9. Kim, S.J., Kang, H.S., Kang, M.S., Yu, X., Park, S.Y., Kim, I.S., Kim, N.S., Kim, S.Z., Kwak, Y.G., and Kim, J.S. (2005). alpha(1)-Agonists-induced Mg(2+) efflux is related to MAP kinase activation in the heart. Biochem. Biophys. Res. Commun. 333, 1132-1138.
10. Klint, P., and Claesson-Welsh, L. (1999). Signal transduction by fibroblast growth factor receptors. Front Biosci. 4, D165-177.
11. Kurosawa, M., Ishizuka, T., and Shimizu, Y. (1993). Formation of phosphatidylinositol-4-phosphate in human peripheral blood eosinophils. Clin. Exp. Allergy 23, 770-776.
12. Laham, R.J., Chronos, N.A., Pike, M., Leimbach, M.E., Udelson, J.E., Pearlman, J.D., Pettigrew, R.I., Whitehouse, M.J., Yoshizawa, C., and Simons, M. (2000). Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study. J. Am. Coll. Cardiol. 36, 2132-2139.
13. Lapidos, K.A., Woodhouse, E.C., Kohn, E.C., and Masiero, L. (2001). Mg(++ )-induced endothelial cell migration: Substratum selectivity and receptor-involvement. Angiogenesis 4, 21-28.
14. Lazarous, D.F., Unger, E.F., Epstein, S.E., Stine, A., Arevalo, J.L., Chew, E.Y., and Quyyumi, A.A. (2000). Basic fibroblast growth factor in patients with intermittent claudication: Results of a phase I trial. J. Am. Coll. Cardiol. 36, 1239-1244.
15. Liao, F., Folsom, A.R., and Brancati, F.L. (1998). Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am. Heart J. 136, 480-490.
16. Maier, J.A., Bernardini, D., Rayssiguier, Y., and Mazur, A. (2004)a. High concentrations of magnesium modulate vascular endothelial cell behaviour in vitro. Biochim. Biophys. Acta 1689, 6-12.
17. Maier, J.A., Malpuech-Brugere, C., Zimowska, W., Rayssiguier, Y., and Mazur, A. (2004b). Low magnesium promotes endothelial cell dysfunction: implications for atherosclerosis, inflammation and thrombosis. Biochim. Biophys. Acta 1689, 13-21.
18. Mussoni, L., Sironi, L., Tedeschi, L., Calvio, A.M., Colli, S., and Tremoli, E. (2001). Magnesium inhibits arterial thrombi after vascular injury in rat: In vitro impairment of coagulation. Thromb. Haemost. 86, 1292-1295.
19. Ornitz, D.M., and Itoh, N. (2001). Fibroblast growth factors. Genome Biol. 2, REVIEWS3005.
20. Peacock, J.M., Folsom, A.R., Arnett, D.K., Eckfeldt, J.H., and Szklo, M. (1999). Relationship of serum and dietary magnesium to incident hypertension: The atherosclerosis risk in communities (ARIC) study. Ann. Epidemiol. 9, 159-165.
21. Powers, C.J., McLeskey, S.W., and Wellstein, A. (2000). Fibroblast growth factors, their receptors and signaling. Endocr. Relat. Cancer 7, 165-197.
22. 2+ influx pathway. Biochem. Biophys. Res. Commun. 167, 1406-1412.
23. Raju, B., Murphy, E., Levy, L.A., Hall, R.D., and London, R.E. (1989). A fluorescent indicator for measuring cytosolic free magnesium. Am. J. Physiol. 256, C540-548.
24. Romani, A.M., and Scarpa, A. (2000). Regulation of cellular magnesium. Front Biosci. 5, D720-734.
25. 2+ uptake in isolated rat myocytes and hepatocytes by protein kinase C. FEBS Lett. 296, 135-140.
26. Romani, A., Marfella, C., and Scarpa, A. (1993). Cell magnesium transport and homeostasis: Role of intracellular compartments. Miner. Electrolyte Metab. 19, 282-289.
27. Scarpa, A., and Brinley, F.J. (1981). In situ measurements of free cytosolic magnesium ions. Fed. Proc. 40, 2646-2652.
28. Schlessinger, J. (2000). Cell signaling by receptor tyrosine kinases. Cell 103, 211-225.
29. 2+ transport in sheep ruminal epithelial cells. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G56-65.
30. Shi, B., Heavner, J.E., Boylan, L.M., Wang, M.J., and Spallholz, J.E. (1995). Dietary magnesium deficiency increases Gi alpha levels in the rat heart after myocardial infarction. Cardiovasc. Res. 30, 923-929.
31. 2+ transport in rat ventricular myocytes. Biophys. J. 89, 3235-3247.
32. 2+ concentration in isolated rat hearts via beta-adrenergic and muscarinic receptors. J. Mol. Cell Cardiol. 30, 2307-2318.
33. Webber, C.A., Chen, Y.Y., Hehr, C. L., Johnston, J., and McFarlane, S. (2005). Multiple signaling pathways regulate FGF-2-induced retinal ganglion cell neurite extension and growth cone guidance. Mol. Cell. Neurosci. 30, 37-47.
34. Wolf, F.I., and Cittadini, A. (1999). Magne sium in cell proliferation and differentiation. Front Biosci. 4, D607-617.
35. Wolf, F.I., and Cittadini, A. (2003). Chemistry and biochemistry of magnesium. Mol. Aspects Med. 24, 3-9.
36. Wolf, F.I., Torsello, A., Fasanella, S., and Cittadini, A. (2003). Cell physiology of magnesium. Mol. Aspects Med. 24, 11-26.
37. 2+ from an intracellular pool in rat sublingual mucous acini. J. Biol. Chem. 271, 29067-29072.